News

    
Directory / Bottin
Contact Us
Directions / Maps
Steering Committee
Events & Seminars
MDRC at the forefront
McGarry Lecture
Cahill Lecture
MDRC Core Facilities
Scientific Links
Education & Employment

    
MDRC Grants
Donations
Non-Profit & Industrial Partners
    
JDRF
CDA
Diabetes Quebec
ADA
IDF
NIH / NIDDK
Alfediam
EASD
 Home / About Us > Dr. Remi Rabasa-Lhoret > Bibliography
Dr. Remi Rabasa-Lhoret - Bibliography (Last Five years)

Published referred papers
  • Rabasa-Lhoret, R, Rasamisoa M, Avignon A, Monnier L. Rare side effect of Fenofibrate. Diabetes & Metab 27, 66-68, 2001.
  • Rabasa-Lhoret, R., Ducros, F., Bourque, J., Chiasson, J.-L. : Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (Ultralente-Lispro). Diabetes Care 24, 625-630, 2001.
  • Rabasa-Lhoret, R., Burelle, Y., Ducros, F., Bourque, J., Lavoie, C., Perronet, F., Massicotte, D., and Chiasson, J.-L. : Use of an alpha-glucosidase inhibitor to maintain glucose homeostasis during postprandial exercise in intensively treated Type 1 diabetic subjects. Diabet Med. 18(9 ): 739-744, 2001.
  • Rabasa-Lhoret, R., Laville M. How to mesure insulin sensitivity in clinical practice? Diabetes & Metab 27, suppl 2, 201-208, 2001. (French)
  • Rabasa-Lhoret, R, Rasamisoa M, Lacroix V, Caubel C, Avignon A, Monnier L. Hyperparathyroidism diagnosed during pregnancy. Presse Médicale 30, 964-65, 2001. (French)
  • Monnier, L, Colette C, Rabasa-Lhoret, R, Lapinski H, Cauble C, Avignon A, Boniface H. Morning hyperglycemic excursions, a constant failure in the metabolic control of non-insulin using patients with type 2 diabetes. Diabetes Care 25, 737-741, 2002
  • Bastard, J-P, Jan V, Maachi M, Rabasa-Lhoret, R et al. Incorporation of non-esterified fatty acids into QUICKI is not relevant in obese subjects during diet inducing weight loss. Diabetes & Metab. 28 (4 Pt 1) : 333-334, 2002.
  • Josse RG, Chiasson J-L, Ryan ED, Lau DCW, Ross SA, Yale J-F, Leiter LA, Maheu P, Tessier D, Wolever T, Gerstein H, Rodger W, Dorman JM, Murphy LJ, Rabasa-Lhoret, R, Meneilly GS. Acarbose in the treatment of elderly patients with type 2 diabetes. Diabetes Res & Clin Pract, 59(1) : 37-42, 2003
  • Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J., Daugaard R. J., Lloberas J., Camps M., Zierath J R., Rabasa-Lhoret, R., Wallberg-Henrikson, H. et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. J. Biol. Chem., 278 (19) 17190-17197, 2003
  • Rome, S., Clément K., Rabasa-Lhoret, R., Loizon, E., Poitou C., Barsh, G.S., Riou, J.-P., Laville, M. and Vidal, H. Microarray profiling of human skeletal muscle reveals that insulin regulates ˜ 800 genes during an hyperinsulinemic clamp. J Biol Chem, 278 (20): 18063-18068, 2003
  • Bastard J-P, Rabasa-Lhoret, R, Maachi, M, Ducluzeau, H, Andreelli, F, Vidal, H. Laville, M. What kind of simple fasting index should be used to estimate insulin sensitivity in humans ? Diabetes Metab , 29 : 285-288, 2003
  • Rabasa-Lhoret, R, Bastard J-P, Jan V, Laville M, et al. Modified QUICKI is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab. 88(10) : 4917-4923, 2003
  • Boukhors Y, Rabasa-Lhoret, R, Langelier H, Soultan M, Lacroix A, Chiasson J-L. The use of information technology for the management of intensive insulin therapy in type 1 diabetes mellitus. Diabetes Metab 29: 619-627, 2003
  • St-Pierre, DH, George, V, Rabasa-Lhoret, R, Poehlman, ET. Genetic variation in response to overfeeding and underfeeding in humans. Journal of Nutrition 20: 145-154, 2004.
  • Karelis AD, Cornus F, Rabasa-Lhoret R, St-Pierre D, Poehlman ET Metabolic and body composition of subgroups of obesity: What do we know? J Clin Endocrinol Metab. 89: 2569-2575, 2004
  • Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre D, Tremblay-Lebeau, Poehlman ET. Metabolic and behavioral characteristics of metabolically obese but normal weight (MONW) women. J Clin Endocrinol Metab. 89: 5013-5020, 2004
  • Karelis AD, Rabasa-Lhoret R, Garrel D, Poehlman ET. Clinical markers for the identification of metabolically healthy but obese (MHO) individuals. Diabetes Obes Metab, 6 :456-457, 2004
  • Chiasson JL, Rabasa-Lhoret R. Prevention of Type 2 diabetes. Insulin resistance and b-cell function. Diabetes 53 : S34-S38, 2004
  • Karelis A, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals. Diabetes & Metabolism 30 : 569-572, 2004
  • Karelis AD, Henry JF, Malita F, St-Pierre DH, Vigneault I, Poehlman ET, Rabasa-Lhoret R. Comparison of Insulin Sensitivity values using the Hyperinsulinemic Euglycemic Clamp: 2 vs. 3 hours. Diabetes & Metab, 30 : 413-414, 2004
  • Costa M, Potvin S, Beauregard G, Rabasa-Lhoret R. Mesurer l’insulinorésistance en pratique quotidienne et en recherche. Sang Thromb Vais. 9 : 455-460, 2004
  • St-Pierre DH, Karelis AD, Cianflone K, Conus F, Michault D, Rabasa-Lhoret R, St-Onge M, Tremblay-Lebeau A, Poehlman ET. Relationship between Ghrelin and energy expenditure in healthy young women. J Clin Endocrinol Metab 89 : 5993-5997, 2004
  • Mignault D, St-Onge M, Allison DB, Rabasa-Lhoret R. Evaluation of a portable health wearÔ armband : A device to measure total daily energy expenditure in free-living type 2 diabetics. Diabetes Care 28 : 225-227 2005
  • Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, Levesque R, Chiasson J-L, Rabasa-Lhoret R. Diatetes: a major co-morbidity of cystic fibrosis. Diabetes & Metab. 31: 221-232, 2005
  • Malita FM, Karelis AD, Toma E, Rabasa-Lhoret R. Effects of different types of exercise on body composition and fat distribution in HIV-infected patients: A brief review. Can J Appl Physiol. 30 : 233-245, 2005
  • Karelis A, Faraj M, Bastard J.-P., St-Pierre D, Brochu M, Prud’homme D, Rabasa-Lhoret R. The metabolically healthy but obese individual state is associated with a favourable inflammatory profile. J Clin Endocrinol Metab. 90:4145-4150, 2005
  • Chiasson J-L, Brindisi M-C, Rabasa-Lhoret R. The prevention of type 2 diabetes: what is the evidence ? Minerva Endocrinol, 2005 30(3):179-91.
  • Karelis AD, Henry JF, St-Pierre DH, Prud’homme D, Rabasa-Lhoret R. Degradation in insulin sensitivity with increasing severity of the metabolic syndrome. Diabetes Obes Metab (in press) 2005
  • St-Pierre D, Faraj M, Conus F, Tremblay-Lebeau A, Karelis A, Cianflone K, Rabasa-Lhoret R. Components of energy balance are independent predictors of ghrelin and adiponectine in young non-obese women. Diabetes & Metab, (in press) 2005
  • Brindisi M-C, Rabasa-Lhoret R, Chiasson J-L. Postprandial hyperglycaemia: to treat or not to treat? Diabetes & Metab, 2005 (in press)
  • Karelis A, St-Pierre D-H, Riou M-E, Bastar J-P, Messier L, Mignault D, Brochu M, Garrel D, Rabasa-Lhoret R. La caractérisation des individus obèses mais métaboliquement normaux: Où en sommes nous ? Sang Thromb Vais, 2005 (in press)
  • Karelis A, Fontaine J, Rabasa-Lhoret R, Prud’homme D, Doucet E, Blanchard C, Garrel D, Strychard I. Psychosocial profile of Metabolically Healthy but Obese post-menopausal woman. A MONET study .Diabetes & Metab, 2005 (in press)
  • Malita F-M, Karelis A-D, St-Pierre A-D, Garrel D, Bastard J-P, Tardif A, Prud’Homme D, Rabasa-Lhoret R. Surrogate indexes vs euglycemic-hyperinsulinemic clamp as an indicator of insulin resistance and cardiovascular risk factors in overweight and obese postmenopausal women: A MONET study. Diabetes & Metab, 2005 (in press)
Book Chapters
  • Monnier L, Rabasa-Lhoret, R., Piperno M, Blotmann M-J. Le diabète : comorbiditées et déficiences multiples, coût socio-économique. In: Diabète et Médecine Physique. Kotzki N, Brunon A., eds. Masson, 1 : 6-12, 2001.
  • Rabasa-Lhoret, R, Laville, M. Physiopathologie des obésités et du diabète de type 2. In Enc med Chir. Elservier. A Grimaldi Ed 10-506-F-10 2003.
  • Rabasa-Lhoret, R, Chiasson J-L. Alpha-glucosidase inhibitors. In International Textbook of diabetes Mellitus 3th Ed. RA DeFronzo, E Ferrannini, H Keen and P Zimmet,.John Wiley & Sons. 49 :901-914, 2004
  • Rabasa-Lhoret, R, Bastard J-P. Méthodes de mesure de la sensibilité à l’insuline. Traité de diabétologie. A Grimaldi Ed., 2004 (Sous presse)
  • Rabasa-Lhoret, R, Chiasson J-L. Alpha-glucosidase inhibitors in the treatment of hyperglycemia. In Therapy for Diabetes Mellitus and Related Disorders. (4th Ed) A Lebovitz Ed. American Diabetes Association, 22: 192-197, 2004
Montreal Diabetes Research Center 2014
Home / About Us   News   Directory / Bottin   Contact Us